Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Jun;37(6):1046–1052. doi: 10.1038/bjc.1978.152

A tumour-associated antigen from the pleural effusion of patients with squamous-cell carcinoma of lung.

A Wolf
PMCID: PMC2009660  PMID: 678426

Abstract

A fraction showing tumour-associated antigenic properties has been isolated from pleural effusions of patients with squamous-cell carcinoma of the lung. Purification of the material was accomplished by ion-exchange and affinity chromatography, and by immunoabsorbents. The antigenic activity was monitored by its inhibitory capacity in a specific complement-dependent cytotoxic system. The final fraction has a mol. wt. of approximately 1.7 X 10(5), as judged by gel filtration on Sephadex G200, and the main component appears to be a glycoprotein with N-acetyl-D-glucosamine groups. The most purified antigen preparation exhibited a highly selective capacity to inhibit in the cytotoxic assay and to bind, when labelled with 125I, to 2 specific antisera. The active fractions isolated from pleural effusions fully crossreacted with fractions prepared from squamous-cell carcinoma extracts. CEA and bacterial antigens were not detected in the material, and the presence of alpha-fetoprotein, HLA and blood-group antigens may be ruled out on account of their respective molecular weights.

Full text

PDF
1046

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clemetson K. J., Bertschmann M., Widmer S., Lüscher E. F. Water-soluble P-815 mastocytoma membrane antigens: separation of tumour-associated antigens from histocompatibility antigens. Immunochemistry. 1976 May;13(5):383–388. doi: 10.1016/0019-2791(76)90372-4. [DOI] [PubMed] [Google Scholar]
  2. Frost M. J., Rogers G. T., Bagshawe K. D. Extraction and preliminary characterization of a human bronchogenic carcinoma antigen. Br J Cancer. 1975 Apr;31(4):379–386. doi: 10.1038/bjc.1975.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Granlund D. J., Ritts R. E., Jr Soluble proteins of human bronchogenic carcinomas. Mayo Clin Proc. 1976 Jan;51(1):19–27. [PubMed] [Google Scholar]
  4. Hunter W. M. Radioimmunoassay and saturation analysis. Preparation and assessment of radioactive tracers. Br Med Bull. 1974 Jan;30(1):18–23. doi: 10.1093/oxfordjournals.bmb.a071161. [DOI] [PubMed] [Google Scholar]
  5. Kelly B., Levy J. G. Evidence for a common tumour-associated antigen in extracts of human bronchogenic carcinoma. Br J Cancer. 1977 Jun;35(6):828–833. doi: 10.1038/bjc.1977.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McCoy J. L., Jerome L. F., Cannon G. B., Weese J. L., Herberman R. B. Reactivity of lung cancer patients in leukocyte migration inhibition assays to 3-M potassium chloride extracts of fresh tumor and tissue-cultured cells derived from lung cancer. J Natl Cancer Inst. 1977 Nov;59(5):1413–1418. doi: 10.1093/jnci/59.5.1413. [DOI] [PubMed] [Google Scholar]
  7. Tillack T. W., Rosai J., Vervynck D. J. Immunologic studies of glycoproteins isolated from cell membranes of human lung carcinomas. J Natl Cancer Inst. 1974 Apr;52(4):1059–1067. doi: 10.1093/jnci/52.4.1059. [DOI] [PubMed] [Google Scholar]
  8. Veltri R. W., Mengoli H. F., Maxim P. E., Westfall S., Gopo J. M., Hauang C. W., Sprinkle P. M. Isolation and identification of human lung tumor-associated antigens. Cancer Res. 1977 May;37(5):1313–1322. [PubMed] [Google Scholar]
  9. Wolf A., Steele K. A., Alexander P. Estimation in sera by radioimmunoassay of a specific membrane antigen associated with a murine lymphoma. Br J Cancer. 1976 Feb;33(2):144–153. doi: 10.1038/bjc.1976.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wolf A., Steele K. A. Separation of a tumour specific transplantation-type antigen from the ascitic fluid of mice bearing a syngeneic lymphoma. Br J Cancer. 1975 Jun;31(6):684–688. doi: 10.1038/bjc.1975.116. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES